Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics

Biological therapy is very effective for treating patients with moderate to severe inflammatory bowel disease (IBD). However, up to 40% can have primary non-response, and up to 50% of the patients can experience a loss of response to anti-tumor necrosis factor therapy. These undesirable outcomes can...

Descripción completa

Detalles Bibliográficos
Autores principales: Deyhim, Tina, Cheifetz, Adam S., Papamichael, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672599/
https://www.ncbi.nlm.nih.gov/pubmed/38002743
http://dx.doi.org/10.3390/jcm12227132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672599/
https://www.ncbi.nlm.nih.gov/pubmed/38002743
http://dx.doi.org/10.3390/jcm12227132

Ejemplares similares